MoneyWorks4Me

Jubilant Pharmova - Quaterly Results

29 May 2023 Evaluate
Net sales declined -16.97%  to  Rs. 1998.40 million from Rs. 2406.90 millions.The Net Loss for the quarter ended March 2023 is Rs. -308.60 millions as compared to Net Profit of Rs. 104.60 millions of corresponding quarter ended March 2022A decline of 158.40 millions was observed in the OP in the quarter ended March 2023 from 275.10 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1998.40 2406.90 -16.97 8101.20 7257.30 11.63 8101.20 7257.30 11.63
Other Income 136.60 72.10 89.46 1378.90 1261.60 9.30 1378.90 1261.60 9.30
PBIDT 158.40 275.10 -42.42 1411.10 1326.20 6.40 1411.10 1326.20 6.40
Interest 57.00 29.20 95.21 185.20 109.90 68.52 185.20 109.90 68.52
PBDT 101.40 245.90 -58.76 1225.90 1216.30 0.79 1225.90 1216.30 0.79
Depreciation 113.70 92.60 22.79 432.50 369.10 17.18 432.50 369.10 17.18
PBT -12.30 153.30 -108.02 793.40 847.20 -6.35 793.40 847.20 -6.35
TAX 296.30 48.70 508.42 294.60 42.30 596.45 294.60 42.30 596.45
Deferred Tax 301.90 48.80 518.65 156.40 -100.50 -255.62 156.40 -100.50 -255.62
PAT -308.60 104.60 -395.03 498.80 804.90 -38.03 498.80 804.90 -38.03
Equity 159.30 159.30 0.00 159.30 159.30 0.00 159.30 159.30 0.00
PBIDTM(%) 7.93 11.43 -30.65 17.42 18.27 -4.68 17.42 18.27 -4.68
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..